Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H12N2O8.Fe.Na |
Molecular Weight | 367.046 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Fe+3].[O-]C(=O)CN(CCN(CC([O-])=O)CC([O-])=O)CC([O-])=O
InChI
InChIKey=MKWYFZFMAMBPQK-UHFFFAOYSA-J
InChI=1S/C10H16N2O8.Fe.Na/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20;;/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20);;/q;+3;+1/p-4
Molecular Formula | Fe |
Molecular Weight | 55.845 |
Charge | 3 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C10H12N2O8 |
Molecular Weight | 288.2109 |
Charge | -4 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | Na |
Molecular Weight | 22.98976928 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524https://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103v=onepage&q&f=falsehttps://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttp://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.htmlCurator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Sources: https://cameochemicals.noaa.gov/chemical/3468 | https://www.ncbi.nlm.nih.gov/pubmed/2135524https://books.google.ru/books?id=vxtxWneRBN4C&pg=PA1103v=onepage&q&f=falsehttps://mistralhowto.wordpress.com/2012/03/12/what-is-pigment-yellow-42-and-what-is-it-used-for/ | http://sensientfoodcolors.com/en-us/confection/iron-oxides-approved-by-the-fda/ | https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=73.2250 | https://www.drugs.com/inactive/ferric-oxide-yellow-381.htmlhttp://www.mfc.co.jp/english/eng/product/sanferol/pdf/fls_gras_notice.pdfhttps://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/205874Orig1s000PharmR.pdfhttp://www.edta-chelate.com/ferric-ammonium-edta-liquid--1640836.html
Curator's Comment: description was created based on several sources, including
http://www.mfc.co.jp/english/eng/product/sanferol/index.html
Ferric Ammonium EDTA Solution is normally used as a photographic chemical for a bleaching agent in the process of colour washing. It is also used as a complexing, and oxidizing agent & as a fertilizer and catalyst. EDTA acid are colourless, water-soluble solid that are widely used to dissolve scale. The usefulness of these ammonium salts arise because of its role as a chelating agent, i.e. its ability to "sequester" metal ions such as Ca2+ and Fe3+.
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: GO:0006927 Sources: https://www.ncbi.nlm.nih.gov/pubmed/21121365 |
|||
Target ID: CHEMBL2364184 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | SANFEROL Approved UseIt has also been reported that SFC preparation improved iron deficiency in a pregnant woman with iron deficiency anemia whose hemoglobin level had not increased after administration of other iron preparations such as ferrous fumarate. A dairy supplemental dose of SFC improved iron deficiency in young women with iron deficiency. |
|||
Inactive ingredient | Oxycontin Approved UseOxyContin is used in the treatment of chronic pain; pain and belongs to the drug class narcotic analgesics. Launch Date1998 |
|||
Palliative | AURYXIA Approved UseFerric Citrate is a phosphate binder indicated for the control of serum phosphorus levels in patients with chronic kidney disease on dialysis. Launch Date2014 |
PubMed
Title | Date | PubMed |
---|---|---|
[Effects of ferric fluoride compounds on dental enamel]. | 1954 Nov 15 |
|
Effect of physical exercise and vitamin C on absorption of ferric sodium citrate. | 1996 Dec |
|
New phosphate binding agents: ferric compounds. | 1999 Jun |
|
Fabrication of FeF3 Nanoflowers on CNT branches and their application to high power lithium rechargeable batteries. | 2010 Dec 7 |
|
Microwave assisted convenient one-pot synthesis of coumarin derivatives via Pechmann condensation catalyzed by FeF3 under solvent-free conditions and antimicrobial activities of the products. | 2014 Aug 26 |
|
Heme Binding by Corynebacterium diphtheriae HmuT: Function and Heme Environment. | 2015 Nov 3 |
|
Superior electrochemical performance of N-doped nanocrystalline FeF(3)/C with a single-step solid-state process. | 2016 Oct 4 |
|
Phosphorus recovery from biogas slurry by ultrasound/H(2)O(2) digestion coupled with HFO/biochar adsorption process. | 2017 Feb |
Sample Use Guides
In Vivo Use Guide
Curator's Comment: Iron oxides black, red and yellow are intended to be used as colourants in feedingstuffs for all animal species without dose or age restriction. The applicant recommends 500–1,200 mg/kg of the additives in complete (and complementary) feedingstuffs as standard dose. http://onlinelibrary.wiley.com/doi/10.2903/j.efsa.2016.4482/full
Unknown
Route of Administration:
Unknown
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/286710
Bovine enamel was treated with 10 mM FeF3 (Ferric fluoride)
Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 10:00:31 GMT 2025
by
admin
on
Wed Apr 02 10:00:31 GMT 2025
|
Record UNII |
403J23EMFA
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
B03AB03
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
||
|
EPA PESTICIDE CODE |
139114
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
||
|
WHO-VATC |
QB03AB03
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
403J23EMFA
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
100000091544
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
C76827
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
152
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
178
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
Ferric sodium EDTA
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
1122
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
5237
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
78292
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
403J23EMFA
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
SUB10560MIG
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
4709
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
m5328
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | Merck Index | ||
|
DB13381
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
105673
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | RxNorm | ||
|
DTXSID5027774
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
239-802-2
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
C1505
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
CONCEPT | Dietary Supplement | ||
|
1614239
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
15708-41-5
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY | |||
|
27461
Created by
admin on Wed Apr 02 10:00:31 GMT 2025 , Edited by admin on Wed Apr 02 10:00:31 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |